271 studies found for:    "Expanded Access" [STUDY-TYPES]
Show Display Options
RSS Create an RSS feed from your search for:
"Expanded Access" [STUDY-TYPES]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Available Omegaven Expanded Access Protocol
Condition: Parenteral Nutrition Associated Liver Disease
Intervention: Drug: Omegaven
2 Approved for marketing Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease
Condition: Iron Overload
Intervention: Drug: deferiprone
3 No longer available Expanded Access Multicenter Study of Lucanix® (Belagenpumatucel-L)
Condition: Non-small Cell Lung Cancer
Intervention: Biological: Lucanix® (belagenpumatucel-L)
4 Temporarily not available Pulmonary MR Angiography and Lower Extremity MR Venous Imaging Using Gadofosveset (Ablavar)
Condition: Pulmonary Embolism
Intervention: Drug: Gadofosveset Triodium
5 No longer available Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: Sirolimus;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Drug: Mycophenolic acid
6 Available An Expanded Access Program With Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer
Condition: Differentiated Thyroid Cancer
Intervention: Drug: Lenvatinib
7 Available Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
8 Temporarily not available Expanded Access Protocol for an Intermediate Size Population - RAVICTI for Byler Disease
Condition: Byler Disease
Intervention: Drug: RAVICTI
9 Available Compassionate Use of Stiripentol in Dravet Syndrome
Condition: Dravet Syndrome
Intervention: Drug: Stiripentol
10 Available INC424 for Patients With Myelofibrosis, Post Polycythemia Myelofibrosis or Post-essential Thrombocythemia Myelofibrosis
Conditions: Myelofibrosis (PMF);   Post Polycythemia Myelofibrosis (PPV MF);   Post-essential Thrombocythemia Myelofibrosis (PET-MF);   Myelofibrosis;   Post Polycythemia Myelofibrosis;   Post-essential Thrombocythemia Myelofibrosis
Intervention: Drug: INC424
11 Available To Validate the Specific Patterns of Magnetocardiography, a Non-invasive Non-contact Examination for Patients With Ischemic Heart Disease or Cardiac Arrhythmia
Condition: Arrhythmia
Intervention: Other: MCG
12 Available The Effect of Adding Magnesium Sulfate to Standard Epidural and Interscalene Block in Treatment of Patients With Chronic Pain
Condition: Pain
Intervention: Drug: Adding Magnesium Sulfate to the standard epidural and interscalene blocks for chronic pain
13 Available An Extended Access Program for Perampanel
Condition: Partial Onset Seizures
Intervention: Drug: Perampanel
14 Available Compassionate Use of Omegaven for Pediatric Patients With Parenteral Nutrition Associated Liver Disease
Conditions: Cholestasis;   Short Bowel Syndrome
Intervention: Drug: Omegaven
15 Available 3,4-Diaminopyridine for Lambert-Eaton Myasthenic Syndrome (LEMS) and Congenital Myasthenia (CM)
Conditions: Lambert-Eaton Myasthenic Syndrome (LEMS);   Congenital Myasthenia (CM)
Intervention: Drug: 3,4-diaminopyridine
16 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Sirolimus;   Biological: Basiliximab;   Drug: Tacrolimus;   Drug: Antibacterial, Antifungal, and Antiviral Prophylaxis;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Clotrimazole;   Drug: Valganciclovir;   Drug: Heparin;   Drug: Enoxaparin;   Drug: Pentoxifylline;   Drug: Aspirin
17 Available Bosutinib Treatment Extension Study Only For Subjects With Chronic Myeloid Leukemia (CML) Who Have Previously Participated In Bosutinib Studies B1871006 Or B1871008
Condition: Chronic Myeloid Leukemia
Intervention: Drug: bosutinib
18 Available Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Condition: Lambert-Eaton Myasthenic Syndrome
Intervention: Drug: 3,4 DAP
19 No longer available Local Open-Label Access Study For Patients Who Completed A1481244 Study In Brazil
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil (Revatio) 20 mg TID
20 Approved for marketing Access Program With Denileukin Diftitox for the Treatment of Patients Currently Receiving Treatment With Commercially Available (Ontak)
Condition: Cancer
Intervention: Drug: Denileukin diftitox (ONTAK)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years